Results 171 to 180 of about 5,392 (213)

Immune responses to bovine respiratory syncytial virus (BRSV) following use of an inactivated BRSV-PI3-Mannheimia haemolytica vaccine and a modified live BRSV–BVDV vaccine

Veterinary Journal, 2004
P, Kerkhofs, M, Tignon, H, Petry, I, Mawhinney, B, Sustronck   +4 more
exaly   +3 more sources

Bovine Respiratory Syncytial Virus (BRSV): A review [PDF]

Acta Veterinaria Scandinavica, 2000
Bovine respiratory syncytial virus (BRSV) infection is the major cause of respiratory disease in calves during the first year of life. The study of the virus has been difficult because of its lability and very poor growth in cell culture. However, during the last decade, the introduction of new immunological and biotechnological techniques has ...
exaly   +3 more sources

Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV

Vaccine, 1999
Formalin-inactivated respiratory syncytial virus (FI-RSV) vaccination has been associated with severe disease in humans. Research in mice suggests that FI-RSV may prime for decreased interferon gamma (IFN-gamma) production at subsequent infection. Interferon-gamma production by peripheral blood mononuclear cells (PBMC) was measured following challenge ...
A R, Woolums, R S, Singer, G A, Boyle, L J, Gershwin   +3 more
exaly   +3 more sources

Efficacy of an Inactivated BRSV Vaccine Against a Virulent BRSV Experimental Challenge in Young Calves

American Association of Bovine Practitioners Conference Proceedings, 2000
The objective of this study was to determine the efficacy of a vaccine containing inactivated Bovine Respiratory Syncytial Virus (BRSV) against a highly virulent BRSV challenge in calves.
Ellis, J., West, K. H., Gallo, G., Conlon, J. Rice   +3 more
openaire   +1 more source

High Mortality Rate Associated with Bovine Respiratory Syncytial Virus (BRSV) Infection in Belgian White Blue Calves Previously Vaccinated with an Inactivated BRSV Vaccine

Journal of Veterinary Medicine, Series B, 2000
SummaryIn a group of 60 Belgian White Blue calves less than 8 months old still housed in barns, a bovine respiratory syncytial virus (BRSV) outbreak was revealed on the basis of a direct diagnosis (immunofluorescence and virus isolation) performed on the lungs of dead animals, and the kinetics of BRSV neutralizing antibodies.
Schreiber, P., Matheise, J., Dessy, F., Heimann, M., Letesson, Jean-Jacques, Coppe, Philippe, Collard, A.   +6 more
openaire   +3 more sources

Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells

Journal of Clinical Microbiology, 1993
The nucleocapsid (N) protein of bovine respiratory syncytial virus (BRSV) in the baculovirus expression system was evaluated as a source of antigen in an enzyme-linked immunosorbent assay (ELISA) for the detection of respiratory syncytial virus (RSV) antibodies.
S K, Samal, M K, Pastey, T, McPhillips, D K, Carmel, S B, Mohanty   +4 more
openaire   +2 more sources

Acute BRSV Infection in Young AI Bulls: Effect on Sperm Quality

Reproduction in Domestic Animals, 2009
ContentsBovine respiratory syncytial virus (BRSV) infection is an important part of the calf pneumonia complex, occasionally affecting even adult cattle. However, the pathogenicity of BRSV in animals older than 6 months is often neglected. Finland is free of many contagious diseases in farm animals, and this gives a good opportunity to study the ...
K, Alm, E, Koskinen, S, Vahtiala, M, Andersson   +3 more
openaire   +2 more sources

Disease facts - Bovine Respiratory Syncytial Virus (BRSV)

Livestock, 2009
BRSV primarily affects young calves between two and five months of age. The clinical signs resulting from the initial viral infection are typical of enzootic pneumonia: pyrexia, tachypnoea, dullness, and anorexia, combined with a soft cough and nasal and ocular discharge.
openaire   +1 more source

Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host

Vaccine, 1997
Previous reports demonstrate that synthetic peptides corresponding to the amino acid region 174-187 of G glycoprotein from subgroups A and B human respiratory syncytial virus (HRSV), containing a Cys-->Ser substitution at position 186, confer complete resistance to immunized BALB/c mice against infection with the respective virus.
N, Bastien, G, Taylor, L H, Thomas, S G, Wyld, C, Simard, M, Trudel   +5 more
exaly   +3 more sources

Comparison of DNA application methods to reduce BRSV shedding in cattle

Vaccine, 1998
We compared the protection afforded by three different DNA application methods against bovine respiratory syncytial virus (BRSV) infection in cattle. A synthetic gene that codes for the G protein of BRSV was inserted into a eukaryotic vector and was used in the vaccine. Intradermal (i.d.) application with a needleless injector (NI), the Pigjet, reduced
Schrijver, R.S., Langedijk, J.P.M., Keil, G.M., Middel, W.G.J., Maris-Veldhuis, M., van Oirschot, J.T., Rijsewijk, F.A.M.   +6 more
exaly   +4 more sources